UTHR in the 13F filings
United Therapeutics Corp Del · CUSIP 91307C102
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 34
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 18 listed it in both
- Shares listed
- 8,464,002
- combined, among listed positions
- Reported value
- $4.6bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 19 buyers (opened or added shares) and 16 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -946,546.
Managers listing UTHR in Q2 2026
34 of 34 holders
Largest increases and reductions, by shares
Increases
- Jane Street Group LLCexisting position · 285,926 shares now+283,167
- Millennium Management LLCexisting position · 409,074 shares now+255,702
- Arrowstreet Capital LPnew position · 83,855 shares now+83,855
- Susquehanna International Group LLPexisting position · 88,579 shares now+58,883
- Man Group PLCexisting position · 134,890 shares now+57,395
Reductions
- Wellington Management Group LLPexisting position · 1,379,025 shares now-885,222
- AQR Capital Management LLCexisting position · 546,002 shares now-280,224
- T. Rowe Price Associates Incexisting position · 243,444 shares now-162,003
- Invesco Ltdexisting position · 473,109 shares now-135,258
- Renaissance Technologies LLCexisting position · 1,708,739 shares now-78,280
New positions and exits
New (7)
Exited (2)
- D. E. Shaw & Co.was $59m
- Walleye Capital LLCwas $1.3m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 5 | $378m | n.a. | n.a. |
| Q3 2013 | 5 | $587m | n.a. | n.a. |
| Q4 2013 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2014 | 8 | $923m | n.a. | n.a. |
| Q2 2014 | 9 | $716m | n.a. | n.a. |
| Q3 2014 | 11 | $1.1bn | n.a. | n.a. |
| Q4 2014 | 10 | $1.2bn | n.a. | n.a. |
| Q1 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q2 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q3 2015 | 16 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 17 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 12 | $869m | n.a. | n.a. |
| Q3 2016 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2016 | 10 | $1.1bn | n.a. | n.a. |
| Q1 2017 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.2bn | n.a. | n.a. |
| Q3 2017 | 8 | $1.1bn | n.a. | n.a. |
| Q4 2017 | 10 | $1.4bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2018 | 10 | $996m | n.a. | n.a. |
| Q3 2018 | 9 | $1.1bn | n.a. | n.a. |
| Q4 2018 | 9 | $1.0bn | n.a. | n.a. |
| Q1 2019 | 9 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 15 | $804m | n.a. | n.a. |
| Q3 2019 | 17 | $913m | n.a. | n.a. |
| Q4 2019 | 14 | $863m | n.a. | n.a. |
| Q1 2020 | 14 | $1.2bn | n.a. | n.a. |
| Q2 2020 | 14 | $1.4bn | n.a. | n.a. |
| Q3 2020 | 10 | $797m | n.a. | n.a. |
| Q4 2020 | 11 | $1.2bn | n.a. | n.a. |
| Q1 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 16 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 14 | $1.7bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.3bn | n.a. | n.a. |
| Q3 2022 | 17 | $2.2bn | n.a. | n.a. |
| Q4 2022 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2023 | 16 | $2.5bn | n.a. | n.a. |
| Q2 2023 | 12 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 13 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.3bn | 8 | 6 |
| Q1 2024 | 19 | $2.2bn | 14 | 6 |
| Q2 2024 | 14 | $2.5bn | 8 | 7 |
| Q3 2024 | 10 | $2.9bn | 6 | 4 |
| Q4 2024 | 14 | $3.3bn | 8 | 4 |
| Q1 2025 | 14 | $2.1bn | 7 | 6 |
| Q2 2025 | 14 | $1.9bn | 9 | 5 |
| Q3 2025 | 16 | $2.6bn | 8 | 10 |
| Q4 2025 | 14 | $3.8bn | 17 | 20 |
| Q1 2026 | 18 | $5.1bn | 18 | 17 |
| Q2 2026 | 14 | $3.5bn | 19 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own UTHR, latest filings →Back to the 13F Explorer →